Tragara Pharmaceuticals, Inc. is a pharmaceutical company based in San Diego, California focused on the clinical and commercial development of proprietary drugs for the treatment of cancer and inflammation-related diseases. Tragara launched operations in January 2007 and is focusing its development resources on two programs: (1) TP1001 for the treatment of inflammation related disorders and (2) TP2001 for the treatment of solid tumors.
Tragara is managed by a team of entrepreneurs with both Big Pharma and Biotech experience in the development and commercialization of oncology therapeutics.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 03/01/07 | Series A | 40M | Unknown |
People
Thomas Estok (President/CEO)
Tracy Lawhon (VP Regulatory Affairs & Development Operations)
Chris LeMasters (Chief Business Officer)
Sara Zaknoen (Chief Medical Officer)
Kim Kamdar (Board Member)
View more details about all 9 people at Tragara Pharmaceuticals